Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation (Summary of Impact of Error on Condensed Consolidated Statement of Operations) (Details)

v3.24.1
Basis of Presentation (Summary of Impact of Error on Condensed Consolidated Statement of Operations) (Details) - USD ($)
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Research and development $ 1,650,050 $ 20,611,127
Total operating expenses 9,951,481 38,156,992
Operating loss (7,882,657) (37,454,937)
Loss before income taxes (8,348,420) (38,777,235)
Net loss $ (8,275,981) $ (38,708,957)
Net loss per basic common shares outstanding $ (0.08) $ (0.48)
Net loss per diluted common shares outstanding $ (0.08) $ (0.48)
As Reported [Member]    
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Research and development   $ 18,744,349
Total operating expenses   36,290,214
Operating loss   (35,588,159)
Loss before income taxes   (36,910,457)
Net loss   $ (36,842,179)
Net loss per basic common shares outstanding   $ (0.46)
Net loss per diluted common shares outstanding   $ (0.46)
Adjustment [Member]    
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Research and development   $ 1,866,778
Total operating expenses   1,866,778
Operating loss   (1,866,778)
Loss before income taxes   (1,866,778)
Net loss   $ (1,866,778)
Net loss per basic common shares outstanding   $ (0.02)
Net loss per diluted common shares outstanding   $ (0.02)